Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Mirati Therapeutics, Inc. (MRTX) since 2014 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Mirati Therapeutics, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1576263.
Total stock buying since 2014: $197,353,606.
Total stock sales since 2014: $610,526,851.
Total stock option exercises since 2014: $13,028,089.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2024 | 0 | $0 | 6,815 | $401,688 | 0 | $0 |
| 2023 | 3,787,710 | $105,298,336 | 19,577 | $832,515 | 0 | $0 |
| 2022 | 0 | $0 | 115,374 | $10,704,034 | 82,959 | $1,575,727 |
| 2021 | 0 | $0 | 504,952 | $90,444,225 | 707,271 | $1,562,233 |
| 2020 | 50,000 | $4,875,000 | 1,567,734 | $231,230,880 | 1,599,511 | $2,977,895 |
| 2019 | 150,000 | $9,300,000 | 3,405,323 | $253,847,316 | 1,666,752 | $2,713,409 |
| 2018 | 593,050 | $23,039,992 | 260,841 | $9,171,421 | 292,176 | $3,386,255 |
| 2017 | 2,224,780 | $20,180,727 | 83,544 | $1,448,826 | 21,499 | $160,244 |
| 2016 | 422,316 | $4,384,551 | 1,009,358 | $9,677,766 | 17,542 | $167,638 |
| 2015 | 1,270,000 | $30,275,000 | 15,500 | $395,730 | 26,916 | $363,443 |
| 2014 | 0 | $0 | 107,332 | $2,372,450 | 14,278 | $121,245 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2024-01 | 0 | $0 | 6,815 | $401,688 | 0 | $0 |
| 2023-12 | 0 | $0 | 2,387 | $137,252 | 0 | $0 |
| 2023-09 | 0 | $0 | 2,388 | $85,084 | 0 | $0 |
| 2023-08 | 3,787,710 | $105,298,336 | 0 | $0 | 0 | $0 |
| 2023-06 | 0 | $0 | 4,647 | $172,217 | 0 | $0 |
| 2023-05 | 0 | $0 | 619 | $28,035 | 0 | $0 |
| 2023-01 | 0 | $0 | 9,536 | $409,927 | 0 | $0 |
| 2022-12 | 0 | $0 | 21,092 | $944,577 | 0 | $0 |
| 2022-11 | 0 | $0 | 69,256 | $6,925,600 | 69,256 | $1,205,746 |
| 2022-08 | 0 | $0 | 10,000 | $855,000 | 10,000 | $270,000 |
| 2022-05 | 0 | $0 | 624 | $39,648 | 0 | $0 |
| 2022-01 | 0 | $0 | 14,402 | $1,939,209 | 3,703 | $99,981 |
| 2021-12 | 0 | $0 | 48,405 | $6,508,766 | 47,204 | $400,761 |
| 2021-04 | 0 | $0 | 2,250 | $401,287 | 2,250 | $15,255 |
| 2021-03 | 0 | $0 | 416,755 | $75,682,414 | 626,190 | $271,469 |
| 2021-02 | 0 | $0 | 3,590 | $693,366 | 3,590 | $168,457 |
| 2021-01 | 0 | $0 | 33,952 | $7,158,392 | 28,037 | $706,291 |
| 2020-12 | 0 | $0 | 63,150 | $15,030,416 | 63,150 | $743,811 |
| 2020-11 | 0 | $0 | 0 | $0 | 10,879 | $130,145 |
| 2020-10 | 0 | $0 | 800,000 | $164,264,616 | 800,006 | $799 |
| 2020-08 | 0 | $0 | 12,250 | $1,591,538 | 12,250 | $220,655 |
| 2020-06 | 0 | $0 | 600,000 | $41,400,000 | 600,006 | $600 |
| 2020-05 | 0 | $0 | 37,334 | $3,927,510 | 37,334 | $860,136 |
| 2020-04 | 0 | $0 | 55,000 | $5,016,800 | 55,557 | $730,207 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2024-01-16 | Hickey Benjamin (EVP, Chief Commercial Officer) | Sale | 1,597 | 59.02 | 94,254 |
| 2024-01-16 | Christensen Jamie (EVP & Chief Scientific Officer) | Sale | 1,597 | 59.02 | 94,254 |
| 2024-01-08 | Hickey Benjamin (EVP, Chief Commercial Officer) | Sale | 2,090 | 58.92 | 123,142 |
| 2024-01-04 | Christensen Jamie (EVP & Chief Scientific Officer) | Sale | 1,531 | 58.81 | 90,038 |
| 2023-12-18 | Christensen Jamie (EVP & Chief Scientific Officer) | Sale | 2,387 | 57.50 | 137,252 |
| 2023-09-08 | Christensen Jamie (EVP & Chief Scientific Officer) | Sale | 2,388 | 35.63 | 85,084 |
| 2023-08-11 | Fuglesang Christopher | Buy | 2,517,946 | 27.80 | 69,998,898 |
| 2023-08-11 | Hasnain Faheem (Director) | Buy | 10,791 | 27.80 | 299,989 |
| 2023-06-02 | Stelzer Laurie (Chief Financial Officer) | Sale | 4,647 | 37.06 | 172,217 |
| 2023-05-24 | Christensen Jamie (EVP & Chief Scientific Officer) | Sale | 619 | 45.29 | 28,035 |
| 2023-01-18 | Cherrington Julie M | Sale | 2,546 | 44.66 | 113,704 |
| 2023-01-17 | Hickey Benjamin (EVP, Chief Commercial Officer) | Sale | 1,566 | 42.38 | 66,367 |
| 2023-01-17 | Christensen Jamie (EVP, Chief Scientific Officer) | Sale | 2,245 | 42.38 | 95,143 |
| 2023-01-17 | Meek David D. (Chief Executive Officer) | Sale | 3,179 | 42.38 | 134,713 |
| 2022-12-21 | Hickey Benjamin (EVP, Chief Commercial Officer) | Sale | 3,248 | 40.41 | 131,264 |
| 2022-12-21 | Baum Charles M (President,Founder,Head of R&D) | Sale | 9,092 | 40.42 | 367,471 |
| 2022-12-21 | Meek David D. (Chief Executive Officer) | Sale | 4,616 | 40.41 | 186,551 |
| 2022-12-16 | Christensen Jamie (EVP, Chief Scientific Officer) | Sale | 2,410 | 43.00 | 103,625 |
| 2022-12-02 | Christensen Jamie (EVP, Chief Scientific Officer) | Sale | 1,726 | 90.19 | 155,666 |
| 2022-11-28 | Baum Charles M (President,Founder,Head of R&D) | Sale | 69,256 | 100.00 | 6,925,600 |
| 2022-11-28 | Baum Charles M (President,Founder,Head of R&D) | Option Ex | 69,256 | 17.41 | 1,205,746 |
| 2022-08-12 | Carter Bruce L A | Sale | 10,000 | 85.50 | 855,000 |
| 2022-08-12 | Carter Bruce L A | Option Ex | 10,000 | 27.00 | 270,000 |
| 2022-05-23 | Christensen Jamie (EVP, Chief Scientific Officer) | Sale | 624 | 63.54 | 39,648 |
| 2022-01-19 | Cherrington Julie M | Sale | 1,475 | 116.07 | 171,203 |
| 2022-01-18 | Hickey Benjamin (EVP, Chief Commercial Officer) | Sale | 627 | 120.48 | 75,542 |
| 2022-01-18 | Christensen Jamie (EVP, Chief Scientific Officer) | Sale | 627 | 120.51 | 75,557 |
| 2022-01-18 | Baum Charles M (President,Founder,Head of R&D) | Sale | 2,517 | 120.48 | 303,253 |
| 2022-01-18 | Baum Charles M (President,Founder,Head of R&D) | Option Ex | 3,703 | 27.00 | 99,981 |
| 2022-01-18 | Reed Vickie S (SVP, Chief Accounting Officer) | Sale | 533 | 120.48 | 64,217 |
| 2022-01-07 | Hickey Benjamin (EVP, Chief Commercial Officer) | Sale | 1,964 | 135.94 | 266,984 |
| 2022-01-07 | Reed Vickie S (SVP, Chief Accounting Officer) | Sale | 345 | 135.94 | 46,899 |
| 2022-01-04 | Christensen Jamie (EVP, Chief Scientific Officer) | Sale | 1,442 | 147.72 | 213,018 |
| 2022-01-04 | Baum Charles M (President,Founder,Head of R&D) | Sale | 4,114 | 148.41 | 610,550 |
| 2022-01-04 | Reed Vickie S (SVP, Chief Accounting Officer) | Sale | 758 | 147.74 | 111,986 |
| 2021-12-06 | Christensen Jamie (EVP, Chief Scientific Officer) | Sale | 1,201 | 131.39 | 157,799 |
| 2021-12-03 | Baum Charles M (President & Head of R&D) | Sale | 47,204 | 134.54 | 6,350,967 |
| 2021-12-03 | Baum Charles M (President & Head of R&D) | Option Ex | 47,204 | 8.49 | 400,761 |
| 2021-04-05 | Carter Bruce L A | Sale | 2,250 | 178.35 | 401,287 |
| 2021-04-05 | Carter Bruce L A | Option Ex | 2,250 | 6.78 | 15,255 |
| 2021-03-19 | Hickey Benjamin (EVP, Chief Commercial Officer) | Sale | 2,369 | 176.56 | 418,258 |
| 2021-03-19 | Hickey Benjamin (EVP, Chief Commercial Officer) | Option Ex | 2,369 | 114.33 | 270,847 |
| 2021-03-10 | Lewis Joseph (10% Owner) | Sale | 410 | 196.38 | 80,517 |
| 2021-03-10 | Lewis Joseph (10% Owner) | Option Ex | 410 | .00 | 0 |
| 2021-03-09 | Lewis Joseph (10% Owner) | Sale | 11,971 | 196.20 | 2,348,734 |
| 2021-03-09 | Lewis Joseph (10% Owner) | Option Ex | 11,971 | .00 | 11 |
| 2021-03-05 | Fuglesang Christopher (10% Owner) | Sale | 400,005 | 181.07 | 72,430,905 |
| 2021-03-05 | Fuglesang Christopher (10% Owner) | Option Ex | 611,440 | .00 | 611 |
| 2021-03-02 | Cherrington Julie M | Sale | 2,000 | 202.00 | 404,000 |
| 2021-02-02 | Faga Daniel (EVP, Chief Operating Officer) | Sale | 1,340 | 194.38 | 260,469 |
| 2021-02-02 | Faga Daniel (EVP, Chief Operating Officer) | Option Ex | 1,340 | 114.33 | 153,202 |
| 2021-02-02 | Carter Bruce L A | Sale | 2,250 | 192.40 | 432,897 |
| 2021-02-02 | Carter Bruce L A | Option Ex | 2,250 | 6.78 | 15,255 |
| 2021-01-29 | Martinez Maria E | Sale | 7,500 | 202.62 | 1,519,612 |
| 2021-01-29 | Martinez Maria E | Option Ex | 7,500 | 39.76 | 298,200 |
| 2021-01-26 | Baum Charles M (President & CEO) | Option Ex | 2,292 | 5.40 | 12,376 |
| 2021-01-21 | Johnson Craig A | Sale | 15,000 | 212.35 | 3,185,250 |
| 2021-01-21 | Johnson Craig A | Option Ex | 15,000 | 20.54 | 308,100 |
| 2021-01-19 | Baum Charles M (President & CEO) | Option Ex | 3,245 | 27.00 | 87,615 |
| 2021-01-07 | Hickey Benjamin (EVP, Chief Commercial Officer) | Sale | 2,078 | 215.82 | 448,471 |
| 2021-01-07 | Faga Daniel (EVP, Chief Operating Officer) | Sale | 2,625 | 215.82 | 566,524 |
| 2021-01-07 | Reed Vickie S (SVP, Chief Accounting Officer) | Sale | 241 | 216.33 | 52,134 |
| 2021-01-06 | Christensen Jamie (EVP, Chief Scientific Officer) | Sale | 1,459 | 213.08 | 310,879 |
| 2021-01-06 | Baum Charles M (President & CEO) | Sale | 4,511 | 213.02 | 960,933 |
| 2021-01-06 | Reed Vickie S (SVP, Chief Accounting Officer) | Sale | 538 | 212.99 | 114,589 |
| 2020-12-18 | Baum Charles M (President & CEO) | Sale | 40,000 | 236.47 | 9,458,880 |
| 2020-12-18 | Baum Charles M (President & CEO) | Option Ex | 40,000 | 8.49 | 339,600 |
| 2020-12-15 | Fuchs Henry J | Sale | 10,000 | 234.33 | 2,343,310 |
| 2020-12-15 | Fuchs Henry J | Option Ex | 10,000 | 20.54 | 205,400 |
| 2020-12-14 | Grey Michael G | Sale | 10,900 | 245.41 | 2,675,023 |
| 2020-12-14 | Grey Michael G | Option Ex | 10,900 | 16.84 | 183,556 |
| 2020-12-14 | Carter Bruce L A | Sale | 2,250 | 245.87 | 553,203 |
| 2020-12-14 | Carter Bruce L A | Option Ex | 2,250 | 6.78 | 15,255 |
| 2020-11-02 | Christensen Jamie (EVP, Chief Scientific Officer) | Option Ex | 10,879 | 11.96 | 130,145 |
| 2020-10-30 | Fuglesang Christopher (10% Owner) | Sale | 400,000 | 202.00 | 80,800,000 |
| 2020-10-30 | Fuglesang Christopher (10% Owner) | Option Ex | 400,003 | .00 | 400 |
| 2020-10-29 | Lewis Joseph (10% Owner) | Sale | 104,564 | 212.26 | 22,194,440 |
| 2020-10-29 | Lewis Joseph (10% Owner) | Option Ex | 104,565 | .00 | 104 |
| 2020-10-28 | Lewis Joseph (10% Owner) | Sale | 295,436 | 207.39 | 61,270,176 |
| 2020-10-28 | Lewis Joseph (10% Owner) | Option Ex | 295,438 | .00 | 295 |
| 2020-08-11 | Carter Bruce L A | Sale | 2,250 | 127.81 | 287,568 |
| 2020-08-11 | Carter Bruce L A | Option Ex | 2,250 | 6.78 | 15,255 |
| 2020-08-10 | Fuchs Henry J | Sale | 10,000 | 130.40 | 1,303,970 |
| 2020-08-10 | Fuchs Henry J | Option Ex | 10,000 | 20.54 | 205,400 |
| 2020-06-12 | Braslyn Ltd. (10% Owner) | Sale | 600,000 | 69.00 | 41,400,000 |
| 2020-06-12 | Braslyn Ltd. (10% Owner) | Option Ex | 600,006 | .00 | 600 |
| 2020-05-18 | Carter Bruce L A | Sale | 4,000 | 106.86 | 427,440 |
| 2020-05-18 | Carter Bruce L A | Option Ex | 4,000 | 6.78 | 27,120 |
| 2020-05-11 | Chen Isan (EVP, Chief Medical Officer) | Sale | 33,334 | 105.00 | 3,500,070 |
| 2020-05-11 | Chen Isan (EVP, Chief Medical Officer) | Option Ex | 33,334 | 24.99 | 833,016 |
| 2020-04-27 | Baum Charles M (President & CEO) | Option Ex | 557 | 5.40 | 3,007 |
| 2020-04-20 | Johnson Craig A | Sale | 15,000 | 93.00 | 1,395,000 |
| 2020-04-20 | Johnson Craig A | Option Ex | 15,000 | 25.84 | 387,600 |
| 2020-04-17 | Baum Charles M (President & CEO) | Sale | 40,000 | 90.55 | 3,621,800 |
| 2020-04-17 | Baum Charles M (President & CEO) | Option Ex | 40,000 | 8.49 | 339,600 |
| 2020-03-27 | Baum Charles M (President & CEO) | Option Ex | 2,291 | 5.40 | 12,371 |
| 2020-03-26 | Christensen Jamie (EVP, Chief Scientific Officer) | Option Ex | 8,058 | 14.96 | 120,563 |
| 2020-02-28 | Baum Charles M (President & CEO) | Option Ex | 2,291 | 5.40 | 12,371 |
| 2020-02-04 | Baum Charles M (President & CEO) | Option Ex | 4,687 | 15.20 | 71,218 |
| 2020-01-29 | Chen Isan (EVP, Chief Medical Officer) | Option Ex | 3,002 | 24.99 | 75,019 |
| 2020-01-10 | Boxer Capital, Llc (10% Owner) | Buy | 50,000 | 97.50 | 4,875,000 |
| 2019-12-24 | Baum Charles M (President & CEO) | Option Ex | 318 | 15.20 | 4,832 |
| 2019-12-23 | Christensen Jamie (EVP, Chief Scientific Officer) | Sale | 6,666 | 125.00 | 833,250 |
| 2019-12-23 | Christensen Jamie (EVP, Chief Scientific Officer) | Option Ex | 6,666 | 5.45 | 36,329 |
| 2019-11-20 | Carter Bruce L A | Sale | 3,000 | 94.74 | 284,220 |
| 2019-11-20 | Carter Bruce L A | Option Ex | 3,000 | 6.78 | 20,340 |
| 2019-11-12 | Grey Michael G | Sale | 3,042 | 102.44 | 311,622 |
| 2019-11-12 | Grey Michael G | Option Ex | 3,500 | 16.84 | 58,940 |
| 2019-08-22 | Baum Charles M (President & CEO) | Sale | 51,810 | 87.68 | 4,542,804 |
| 2019-08-22 | Baum Charles M (President & CEO) | Option Ex | 52,368 | 12.96 | 678,846 |
| 2019-08-21 | Carter Bruce L A | Sale | 3,000 | 89.24 | 267,720 |
| 2019-08-21 | Carter Bruce L A | Option Ex | 3,000 | 6.78 | 20,340 |
| 2019-08-12 | Grey Michael G | Sale | 6,084 | 92.67 | 563,834 |
| 2019-08-12 | Grey Michael G | Option Ex | 7,000 | 16.84 | 117,880 |
| 2019-07-23 | Aghazadeh Behzad | Sale | 62,500 | 101.88 | 6,367,500 |
| 2019-07-17 | Boxer Capital, Llc (10% Owner) | Sale | 725,008 | 100.88 | 73,135,182 |
| 2019-05-22 | Carter Bruce L A | Sale | 3,000 | 75.20 | 225,597 |
| 2019-05-22 | Carter Bruce L A | Option Ex | 3,000 | 6.78 | 20,340 |
| 2019-05-16 | Donadio Jamie A (Sr. VP, CFO) | Sale | 7,500 | 75.00 | 562,500 |
| 2019-05-16 | Donadio Jamie A (Sr. VP, CFO) | Option Ex | 7,500 | 5.50 | 41,250 |
| 2019-05-13 | Grey Michael G | Sale | 5,760 | 65.67 | 378,259 |
| 2019-05-13 | Grey Michael G | Option Ex | 7,100 | 16.84 | 119,564 |
| 2019-03-20 | Aghazadeh Behzad | Sale | 23,781 | 72.80 | 1,731,256 |
| 2019-03-19 | Aghazadeh Behzad | Sale | 100,000 | 73.43 | 7,343,000 |
| 2019-03-18 | Aghazadeh Behzad | Sale | 125,000 | 76.55 | 9,568,750 |
| 2019-03-01 | Braslyn Ltd. (10% Owner) | Sale | 275,000 | 69.00 | 18,975,000 |
| 2019-03-01 | Braslyn Ltd. (10% Owner) | Option Ex | 275,004 | .00 | 275 |
| 2019-03-01 | Boxer Capital, Llc (10% Owner) | Sale | 425,000 | 69.00 | 29,325,000 |
| 2019-03-01 | Boxer Capital, Llc (10% Owner) | Option Ex | 425,006 | .00 | 425 |
| 2019-02-25 | Baum Charles M (President & CEO) | Sale | 51,810 | 76.95 | 3,986,727 |
| 2019-02-25 | Baum Charles M (President & CEO) | Option Ex | 51,810 | 8.50 | 440,385 |
| 2019-02-21 | Baum Charles M (President & CEO) | Option Ex | 3,623 | 17.30 | 62,677 |
| 2019-02-20 | Aghazadeh Behzad | Sale | 686,820 | 73.00 | 50,137,860 |
| 2019-02-20 | Carter Bruce L A | Sale | 3,000 | 73.58 | 220,727 |
| 2019-02-20 | Carter Bruce L A | Option Ex | 3,000 | 6.78 | 20,340 |
| 2019-02-15 | Donadio Jamie A (Sr. VP, CFO) | Sale | 7,500 | 75.00 | 562,500 |
| 2019-02-15 | Donadio Jamie A (Sr. VP, CFO) | Option Ex | 7,500 | 5.40 | 40,500 |
| 2019-02-14 | Lemasters Christopher C. (EVP, Chief Business Officer) | Sale | 60,000 | 71.85 | 4,311,120 |
| 2019-02-14 | Lemasters Christopher C. (EVP, Chief Business Officer) | Option Ex | 60,000 | 6.45 | 387,000 |
| 2019-01-29 | Johnson Craig A | Sale | 17,000 | 61.46 | 1,044,752 |
| 2019-01-29 | Johnson Craig A | Option Ex | 17,000 | 9.72 | 165,240 |
| 2019-01-23 | Chen Isan (EVP, Chief Medical Officer) | Option Ex | 870 | 17.30 | 15,051 |
| 2019-01-17 | Boxer Capital, Llc (10% Owner) | Buy | 150,000 | 62.00 | 9,300,000 |
| 2019-01-11 | Reisman Neil (10% Owner) | Option Ex | 25,972 | 15.53 | 403,215 |
| 2019-01-09 | Boxer Capital, Llc (10% Owner) | Sale | 150,000 | 51.30 | 7,695,450 |
| 2019-01-09 | Boxer Capital, Llc (10% Owner) | Option Ex | 150,003 | .00 | 150 |
| 2019-01-08 | Davis Aaron I. (Director) | Sale | 10,000 | 52.80 | 528,000 |
| 2019-01-08 | Boxer Capital, Llc (10% Owner) | Sale | 550,000 | 52.38 | 28,806,250 |
| 2019-01-08 | Boxer Capital, Llc (10% Owner) | Option Ex | 550,012 | .00 | 550 |
| 2019-01-07 | Davis Aaron I. (Director) | Sale | 40,000 | 46.41 | 1,856,519 |
| 2018-12-26 | Christensen Jamie (EVP, Chief Scientific Officer) | Option Ex | 5,169 | 17.41 | 89,992 |
| 2018-08-24 | Baum Charles M (President & CEO) | Option Ex | 11,486 | 17.41 | 199,971 |
| 2018-08-23 | Baum Charles M (President & CEO) | Sale | 51,810 | 57.71 | 2,990,162 |
| 2018-08-23 | Baum Charles M (President & CEO) | Option Ex | 51,810 | 8.50 | 440,385 |
| 2018-07-16 | Chen Isan (EVP, Chief Medical Officer) | Option Ex | 1,867 | 19.46 | 36,331 |
| 2018-06-27 | Christensen Jamie (SVP, Chief Scientific Officer) | Sale | 4,999 | 50.30 | 251,449 |
| 2018-06-27 | Christensen Jamie (SVP, Chief Scientific Officer) | Option Ex | 4,999 | 5.50 | 27,494 |
| 2018-06-26 | Christensen Jamie (SVP, Chief Scientific Officer) | Sale | 5,208 | 48.95 | 254,905 |
| 2018-06-26 | Christensen Jamie (SVP, Chief Scientific Officer) | Option Ex | 5,208 | 5.40 | 28,123 |
| 2018-06-11 | Aghazadeh Behzad | Buy | 400,000 | 38.85 | 15,540,000 |
| 2018-06-07 | Lewis Joseph (10% Owner) | Buy | 193,050 | 38.85 | 7,499,992 |
| 2018-04-25 | Chen Isan (EVP, Chief Medical Officer) | Option Ex | 13,038 | 15.03 | 195,935 |
| 2018-03-09 | Christensen Jamie (SVP, Chief Scientific Officer) | Sale | 22,000 | 33.00 | 726,044 |
| 2018-03-09 | Christensen Jamie (SVP, Chief Scientific Officer) | Option Ex | 22,000 | 21.30 | 468,666 |
| 2018-03-09 | Donadio Jamie A (Sr. VP, CFO) | Sale | 12,100 | 35.00 | 423,500 |
| 2018-03-09 | Donadio Jamie A (Sr. VP, CFO) | Option Ex | 12,100 | 17.41 | 210,661 |
| 2018-03-01 | Donadio Jamie A (Sr. VP, CFO) | Sale | 51,875 | 27.44 | 1,423,294 |
| 2018-03-01 | Donadio Jamie A (Sr. VP, CFO) | Option Ex | 51,875 | 6.07 | 314,725 |
| 2018-02-23 | Baum Charles M (President & CEO) | Sale | 51,810 | 28.23 | 1,462,337 |
| 2018-02-23 | Baum Charles M (President & CEO) | Option Ex | 51,810 | 8.50 | 440,385 |
| 2018-02-06 | Christensen Jamie (SVP, Chief Scientific Officer) | Sale | 23,000 | 30.00 | 690,000 |
| 2018-02-06 | Christensen Jamie (SVP, Chief Scientific Officer) | Option Ex | 23,000 | 21.30 | 489,969 |
| 2018-01-26 | Christensen Jamie (SVP, Chief Scientific Officer) | Sale | 12,500 | 26.11 | 326,425 |
| 2018-01-26 | Christensen Jamie (SVP, Chief Scientific Officer) | Option Ex | 12,500 | 5.40 | 67,500 |
| 2018-01-16 | Christensen Jamie (SVP, Chief Science Officer) | Sale | 10,814 | 27.00 | 291,978 |
| 2018-01-16 | Christensen Jamie (SVP, Chief Science Officer) | Option Ex | 10,814 | 17.41 | 188,271 |
| 2018-01-11 | Christensen Jamie (SVP, Chief Science Officer) | Sale | 14,725 | 22.50 | 331,327 |
| 2018-01-11 | Christensen Jamie (SVP, Chief Science Officer) | Option Ex | 14,500 | 12.96 | 187,847 |
| 2017-11-16 | Aghazadeh Behzad | Buy | 650,000 | 13.00 | 8,450,000 |
| 2017-11-16 | Braslyn Ltd. (10% Owner) | Buy | 400,000 | 13.00 | 5,200,000 |
| 2017-11-16 | Kotler Kevin | Sale | 60,000 | 18.05 | 1,083,000 |
| 2017-11-16 | Christensen Jamie (SVP, Chief Science Officer) | Sale | 10,275 | 18.00 | 184,950 |
| 2017-11-16 | Christensen Jamie (SVP, Chief Science Officer) | Option Ex | 10,000 | 8.50 | 85,000 |
| 2017-11-02 | Christensen Jamie (SVP, Chief Science Officer) | Sale | 7,499 | 14.00 | 104,986 |
| 2017-11-02 | Christensen Jamie (SVP, Chief Science Officer) | Option Ex | 7,499 | 5.50 | 41,244 |
| 2017-10-04 | Christensen Jamie (SVP, Chief Science Officer) | Sale | 4,000 | 14.00 | 56,000 |
| 2017-10-04 | Christensen Jamie (SVP, Chief Science Officer) | Option Ex | 4,000 | 8.50 | 34,000 |
| 2017-09-21 | Tuesday Thirteen Inc. (10% Owner) | Sale | 1,000 | 10.65 | 10,650 |
| 2017-09-15 | Christensen Jamie (SVP, Chief Science Officer) | Sale | 770 | 12.00 | 9,240 |
| 2017-01-26 | Braslyn Ltd. (10% Owner) | Buy | 48,169 | 5.45 | 262,280 |
| 2017-01-25 | Braslyn Ltd. (10% Owner) | Buy | 30,600 | 5.42 | 165,852 |
| 2017-01-24 | Braslyn Ltd. (10% Owner) | Buy | 27,682 | 5.32 | 147,268 |
| 2017-01-23 | Braslyn Ltd. (10% Owner) | Buy | 19,251 | 5.27 | 101,452 |
| 2017-01-20 | Braslyn Ltd. (10% Owner) | Buy | 23,873 | 5.42 | 129,391 |
| 2017-01-19 | Braslyn Ltd. (10% Owner) | Buy | 21,085 | 5.48 | 115,545 |
| 2017-01-18 | Braslyn Ltd. (10% Owner) | Buy | 16,200 | 5.50 | 89,100 |
| 2017-01-17 | Braslyn Ltd. (10% Owner) | Buy | 17,800 | 5.50 | 97,900 |
| 2017-01-13 | Braslyn Ltd. (10% Owner) | Buy | 52,311 | 5.49 | 287,187 |
| 2017-01-12 | Braslyn Ltd. (10% Owner) | Buy | 49,776 | 5.50 | 273,768 |
| 2017-01-06 | Braslyn Ltd. (10% Owner) | Buy | 581,870 | 5.60 | 3,258,472 |
| 2017-01-06 | Fuglesang Christopher (10% Owner) | Buy | 286,163 | 5.60 | 1,602,512 |
| 2016-06-14 | Baum Charles M (PRESIDENT & CEO) | Buy | 20,000 | 7.05 | 141,080 |
| 2016-06-09 | Baker Bros. Advisors (gp) Llc (10% Owner) | Sale | 545,058 | 9.48 | 5,166,604 |
| 2016-06-08 | Baker Bros. Advisors (gp) Llc (10% Owner) | Sale | 158,100 | 9.21 | 1,456,417 |
| 2016-06-07 | Braslyn Ltd. (10% Owner) | Buy | 161,751 | 9.49 | 1,535,016 |
| 2016-06-07 | Baker Bros. Advisors (gp) Llc (10% Owner) | Sale | 296,200 | 9.44 | 2,795,535 |
| 2016-06-06 | Braslyn Ltd. (10% Owner) | Buy | 215,151 | 10.31 | 2,217,346 |
| 2016-03-29 | Braslyn Ltd. (10% Owner) | Buy | 3,400 | 19.09 | 64,906 |
| 2016-03-28 | Braslyn Ltd. (10% Owner) | Buy | 300 | 19.48 | 5,844 |
| 2016-03-24 | Braslyn Ltd. (10% Owner) | Buy | 20,548 | 19.36 | 397,809 |
| 2016-03-18 | Braslyn Ltd. (10% Owner) | Buy | 1,166 | 19.34 | 22,550 |
| 2016-01-15 | Gergen Mark J (Executive VP, COO) | Sale | 10,000 | 25.92 | 259,210 |
| 2016-01-15 | Gergen Mark J (Executive VP, COO) | Option Ex | 15,000 | 8.50 | 127,500 |
| 2016-01-13 | Chen Isan (Sr.Vice President, Chief Medi) | Option Ex | 2,542 | 15.79 | 40,138 |
| 2015-09-16 | Baker Bros. Advisors (gp) Llc (10% Owner) | Buy | 150,000 | 45.00 | 6,750,000 |
| 2015-09-16 | Mva Investors, Llc (10% Owner) | Buy | 45,000 | 45.00 | 2,025,000 |
| 2015-05-26 | Christensen Jamie (SVP & Chief Scientific Officer) | Sale | 4,750 | 28.07 | 133,337 |
| 2015-05-26 | Christensen Jamie (SVP & Chief Scientific Officer) | Option Ex | 4,750 | 17.41 | 82,697 |
| 2015-03-09 | Chen Isan (Chief Medical & Dev't Officer) | Option Ex | 12,666 | 15.79 | 199,996 |
| 2015-03-05 | Christensen Jamie (SVP & Chief Scientific Officer) | Sale | 6,000 | 25.59 | 153,570 |
| 2015-03-05 | Christensen Jamie (SVP & Chief Scientific Officer) | Option Ex | 6,000 | 8.50 | 51,000 |
| 2015-02-19 | Christensen Jamie (SVP & Chief Scientific Officer) | Sale | 3,100 | 23.02 | 71,377 |
| 2015-02-19 | Christensen Jamie (SVP & Chief Scientific Officer) | Option Ex | 3,100 | 8.50 | 26,350 |
| 2015-02-17 | Christensen Jamie (SVP & Chief Scientific Officer) | Sale | 1,650 | 22.70 | 37,446 |
| 2015-02-17 | Christensen Jamie (SVP & Chief Scientific Officer) | Option Ex | 400 | 8.50 | 3,400 |
| 2015-02-03 | Isaly Samuel D | Buy | 100,000 | 20.00 | 2,000,000 |
| 2015-01-29 | 667, L.p. (10% Owner) | Buy | 425,000 | 20.00 | 8,500,000 |
| 2015-01-29 | Mva Investors, Llc (10% Owner) | Buy | 550,000 | 20.00 | 11,000,000 |
| 2014-12-05 | Christensen Jamie (SVP & Chief Scientific Officer) | Option Ex | 2,500 | 8.50 | 21,250 |
| 2014-07-25 | Baum Charles M (President and CEO) | Option Ex | 11,778 | 8.49 | 99,995 |
| 2014-07-01 | Isaly Samuel D | Sale | 5,000 | 20.04 | 100,200 |
| 2014-06-30 | Isaly Samuel D | Sale | 14,000 | 20.72 | 290,080 |
| 2014-06-27 | Isaly Samuel D | Sale | 88,332 | 22.44 | 1,982,170 |
Insider trading activities including stock purchases, stock sales, and option exercises of MRTX listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Mirati Therapeutics, Inc. (symbol MRTX, CIK number 1576263) see the Securities and Exchange Commission (SEC) website.